Novozymes Wins $15M From Danish Rival
Danisco A/S has agreed to pay rival Danish biotech company Novozymes A/S $15.3 million to settle charges that it infringed a patent for the enzyme Spezyme Ethyl, which is used in...To view the full article, register now.
Already a subscriber? Click here to view full article